Azelead Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Liquidation

Azelead General Information

Description

Developer of decision support models designed to study response to a therapeutic treatment. The company's models are developed using zebrafish, a completely transparent fish that allows real-time visualization of the efficiency of a drug and its side effects on the body, enabling pharmacists to prevent the appearance of metastatic cancers and help the development of effective and less toxic anti-cancer drugs.

Contact Information

Website
www.azelead.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 377 rue du Professeur Blayac
  • 34080 Montpellier
  • France
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 377 rue du Professeur Blayac
  • 34080 Montpellier
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Azelead Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Bankruptcy: Liquidation 06-Jul-2023 Completed Bankruptcy: Liquidation
4. Accelerator/Incubator 01-Sep-2021 Completed Generating Revenue
3. Angel (individual) 01-Jul-2016 Completed Generating Revenue
2. Angel (individual) Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Azelead’s complete valuation and funding history, request access »

Azelead Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
To view Azelead’s complete cap table history, request access »

Azelead Patents

Azelead Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3062796-A1 Use of a compound belonging to the diuretics family to treat cancer Active 10-Feb-2017
FR-3062796-B1 Use of a compound belonging to the diuretics family to treat cancer Inactive 10-Feb-2017
EP-3579839-A1 Use of a compound of the diuretics class for treating cancer Inactive 10-Feb-2017
US-20230137849-A1 Use of a compound of the diuretics class for treating cancer Inactive 10-Feb-2017
WO-2018146390-A1 Use of a compound of the diuretics class for treating cancer Inactive 10-Feb-2017 A61K31/549
To view Azelead’s complete patent history, request access »

Azelead Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Azelead FAQs

  • When was Azelead founded?

    Azelead was founded in 2014.

  • Where is Azelead headquartered?

    Azelead is headquartered in Montpellier, France.

  • What is the size of Azelead?

    Azelead has 3 total employees.

  • What industry is Azelead in?

    Azelead’s primary industry is Decision/Risk Analysis.

  • Is Azelead a private or public company?

    Azelead is a Private company.

  • What is Azelead’s current revenue?

    The current revenue for Azelead is .

  • How much funding has Azelead raised over time?

    Azelead has raised $219K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process